Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, ...

Male infertility can impact pregnancy chances more than many realise. An expert explains key causes, genetic factors, warning signs, and important tests couples should consider when trying to conceive ...

In an interview with Jay Salazar from Panther Life Sciences, we discuss microarray patch (MAP) technology and its potential ...

A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in advanced automation for regulated industries, has been announced.

Methods developed and validated to establish the “World Bank of NK Cells” from healthy donors and cancer patientsSingle ...

Infectious keratitis remains a leading cause of corneal blindness and visual impairment worldwide, with bacterial, fungal, amoebic and viral pathogens presenting major diagnostic and therapeutic ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers.

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

Understand the importance of targeted assays in personalised medicine and how early decisions shape clinical outcomes.

According to results published October 20, 2025, in the New England Journal of Medicine, a newly developed, tiny, and wireless retinal implant device is helping restore vision in individuals with ...

When analyzing the drug delivery product pipeline, three key technologies stand out. Check out the latest market research.